FDA Review Period Extended for Nutrition 21's Chromium Picolinate Diabetes-Related Qualified Health Claim Petition
Posted on: Wednesday, 17 August 2005, 18:00 CDT
The Food and Drug Administration (FDA) has requested a two week extension for the review of Nutrition 21, Inc.'s (Nasdaq: NXXI) qualified health claim petition associating chromium picolinate with a reduced risk of insulin resistance, type 2 diabetes and related diseases. The company has agreed to the extension.
About Nutrition 21
Nutrition 21 is a nutritional bioscience company and the maker of chromium-based supplements with health benefits substantiated by clinical research. The company markets Chromax chromium picolinate, which is the most-studied form of the essential mineral chromium. Nutrition 21 holds 36 patents for nutrition products and uses, 27 of which are for chromium compounds and their uses. More information is available at www.nutrition21.com.
Source: Business Wire
Related Articles
- Clinical Study Results: Nutrition 21's Iceland Health(R) Chromax(R) Chromium Picolinate Reduces Hunger, Food Intake and Cravings
- Nutrition 21 Reports That National Toxicology Program Studies Support the Safety of Chromium Picolinate
- Nutrition 21 Receives Commitment From Two Major Retailers for Its Chromax(R) Chromium Picolinate
- Nutrition 21 Announces Supply & Licensing Agreement With CNS, Inc. For Chromax(R) Chromium Picolinate Inclusion in FiberChoice(R) Weight Management Chewable Tablets
- Nutrition 21 Receives Widespread Approval in Europe for the Continued Sale of Chromax(R) Chromium Picolinate and Zinmax(R) Zinc Picolinate
- Nutrition 21 Provides Scientific Updates On Diachrome-R- And Chromax-R- Chromium Picolinate
- Nutrition 21 Announces FDA Review Period Extension for Chromium Picolinate and Diabetes-Related Health Claims
- Three New Studies Confirm Safety of Chromium Picolinate
- Three New Studies Confirm Safety of Chromium Picolinate; Human Clinical Data Presented at 25th American College of Toxicology Conference
 |
 |
User Comments (0)
RSS Feeds